ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc (“L&G”) confirming its holding in ImmuPharma of 4,446,545 million Ordinary Shares in the capital of the Company, representing 3.35% of ImmuPharma’s total voting rights figure of 132,522,985 Ordinary Shares.
Commenting, Tim McCarthy, Chairman of ImmuPharma, said: “We are delighted to be able to disclose Legal & General’s increased holding in ImmuPharma as one of our existing major institutional investors which participated in our recent successful GBP4.1 million fundraising demonstrating its continued support for ImmuPharma.”
Full disclosure of the TR1 is shown below:
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
-----------------------------------------------
1. Identity of the issuer or ImmuPharma Plc
the underlying issuer
of existing shares to which
voting rights are
attached:
------------------------------------------------------------ -----------------------------
2. Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights Yes
--------------------------------------------------------------- --------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached.
--------------------------------------------------------------- --------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------- --------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------- --------------------------
Other (please
specify):
-------------------------------------------------------- ----- --------------------------
3. Full name of person(s) Legal & General Group Plc
subject to the (L&G)
notification obligation:
---------------------------------------------------------- -------------------------------
4. Full name of shareholder(s) Legal & General Assurance
(if different from 3.): Society Limited (LGAS)
---------------------------------------------------------- -------------------------------
16 March 2017
5. Date of the transaction
and date on
which the threshold is
crossed or
reached:
---------------------------------------------------------- -------------------------------
6. Date on which issuer 17 March 2017
notified:
---------------------------------------------------------- -------------------------------
7. Threshold(s) that is/are L&G (Above 3%)
crossed or
reached:
---------------------------------------------------------- -------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------
Class/type Situation Resulting situation after the
of previous triggering transaction
shares to the triggering
transaction
if possible
using
the ISIN
CODE
------------- ------------------------------- ----------------------------------------------------------
Number Number Number of voting % of voting
of of rights rights
Shares Voting
Rights
------------- --------------- -------------- ------------ ----------------------- -------------------
Number Direct Indirect Direct Indirect
of shares
------------- ------------- ------------- ------------ ----------- ---------- -------- ---------
ORD GBP
0.10 Below 3% 4,446,545 4,446,545 - 3.35% -
------------- ------------------------------- ------------ ----------- ---------- --------
